Hospira Supports Tsunami Disaster Relief With $300,000 and Medical Product Donations LAKE FOREST, Ill., Dec. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. and its employees today announced that they are contributing $300,000, as well as product donations, to support the relief efforts related to last weekend's earthquake and tsunamis affecting southern Asia and the eastern coast of Africa. Hospira also will match financial contributions from its employees to support relief efforts, up to $50,000. (Logo: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO ) "The Hospira family expresses deep sympathy to all those affected by this terrible tragedy," said Christopher B. Begley, chief executive officer, Hospira. "Hospira is committed to our global community, and we hope that our donations will help restore health and wellness to this devastated region." Hospira contributed a $250,000 cash grant to the American Red Cross International Response Fund and a $50,000 cash grant to AmeriCares, a leading non-profit aid organization, to support their efforts for this tragedy. In addition, Hospira donated over 29,000 pounds of medical products via AmeriCares. Hospira's donation included a variety of intravenous (I.V.) solutions and injectable drugs, as well as sterile water. Hospira's products are being included in AmeriCares airlifts to aid disaster survivors in Sri Lanka, India and Indonesia. For more information about the American Red Cross or AmeriCares, please visit their Web sites at http://www.redcross.org/ and http://www.americares.org/, respectively. About Hospira Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories, Hospira is a new company with 70 years of service to the hospital industry. The company's portfolio includes one of the industry's broadest lines of generic acute-care injectables, which help address the high cost of proprietary pharmaceuticals in hospitals; integrated solutions for medication management and infusion therapy; and a full-service contract manufacturing business. Headquartered in Lake Forest, Ill., north of Chicago, Hospira has more than 14,000 employees and 15 manufacturing facilities worldwide. Hospira's news releases and other information can be found at http://www.hospira.com/ . Private Securities Litigation Reform Act of 1995 -- A Caution Concerning Forward-Looking Statements Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth in the information statement under the heading "Risk Factors" in the most recent version of the Form 10 filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments. http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Jason Hodges, +1-224-212-2863, or Financial Community, Lynn McHugh, +1-224-212-2363, both of Hospira, Inc. Web site: http://www.hospira.com/

Copyright